This case-control study estimates the effectiveness of maternal postpartum messenger RNA (mRNA) COVID-19 vaccination against Delta and Omicron SARS-CoV-2 infection and hospitalization in infants younger than 6 months.
Home>>Clinical Practice Guidelines>>Postpartum mRNA COVID-19 Vaccination Against SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months
Clinical Practice Guidelines